07/31
Headlines

NYSE:ABBV

Market Movers: AbbVie Inc. (NYSE:ABBV), Xerox Corporation (NYSE:XRX), SunTrust Banks (NYSE:STI), Danaher Corp. (NYSE:DHR), Eagle Bancorp Montana, Inc. (NASDAQ:EBMT)

Jason Knox02 mins

AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 21.70% and weekly performance is 1.16%. On last trading day company shares ended up $55.60. AbbVie Inc. (NYSE:ABBV) distance from 50-day simple moving average (SMA50) is 2.25%. One such investor is Robert Zapfel. He is the President of Services Business at Xerox Corp. (NYSE:XRX)….

Read More

Eye Catching Stocks: AbbVie Inc. (NYSE:ABBV), DepoMed Inc. (NASDAQ:DEPO), Misonix Inc. (NASDAQ:MSON), Bebe Stores, Inc. (NASDAQ:BEBE)

Kristen Barton02 mins

AbbVie (NASDAQ:ABBV) had its target price boosted by Credit Suisse from $60.00 to $63.00 in a report issued on Wednesday. They currently have an outperform rating on the stock.AbbVie Inc. (NYSE:ABBV) shares moved down -0.21% in last trading session and ended the day at $55.75. ABBV Gross Margin is 76.40% and its return on assets is…

Read More

Hot Stocks: VMware, Inc. (NYSE:VMW), Honeywell International Inc. (NYSE:HON), AbbVie Inc (NYSE:ABBV), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Richard Atkins03 mins

VMware, Inc (NYSE:VMW) COO Carl M. Eschenbach unloaded 5,897 shares of the stock in a transaction dated Wednesday, May 21st. The shares were sold at an average price of $95.05, for a total value of $560,509.85. Following the sale, the chief operating officer now directly owns 81,879 shares of the company’s stock, valued at approximately…

Read More

DRug Active runners: Pfizer Inc. (NYSE:PFE), Sanofi SA (ADR) (NYSE:SNY), AbbVie Inc (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ)

Chris Lewis03 mins

Three years after Pfizer Inc. (NYSE:PFE) dropped a bombshell on its plans to lay off more than 1000 workers. The biopharmaceutical company has come back with some of the best news, on how it plans to use the vacated Groton site. In a joint announcement, Gov. Dannel P. Malloy and Pfizer confirmed that two buildings…

Read More

Trader’s Alert: AbbVie Inc (NYSE:ABBV), NeoStem Inc (NASDAQ:NBS), Occidental Petroleum Corporation (NYSE:OXY), Wells Fargo & Co (NYSE:WFC)

Jason Knox02 mins

AbbVie, Inc. (NYSE:ABBV) announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA (adalimumab) as a treatment for fingernail psoriasis in patients with moderate to severe chronic plaque psoriasis, an area of unmet need. Currently there are no approved treatments for fingernail psoriasis. AbbVie Inc (NYSE:ABBV) stock performance…

Read More